Proteomic analysis of differential protein expression in human atherosclerotic plaque progression

In this study, differential protein expression was assessed during human atherosclerotic plaque progression. A multifaceted approach was used in which differential protein expression was studied by two‐dimensional (2D) gel electrophoresis and validated in individual patients using western blotting and immunohistochemistry. 2D profiles of whole‐mount advanced stable lesions were compared to those of plaques containing a thrombus. Mass spectrometry analysis identified vinexin‐β and α1‐antitrypsin (AAT) in the same spot that was differentially expressed in plaques with a thrombus. Immunohistochemistry and western blotting showed limited expression of both vinexin‐β and AAT in early lesions, whereas high expression of both proteins was found in advanced lesions. Differential expression of vinexin‐β in lesions with a thrombus compared to stable plaques could not be confirmed, indicating the importance of validation of proteomic analysis. For AAT, western blotting of 2D gels revealed expression of six isoforms in advanced plaques, one of which was confirmed to be solely expressed in thrombus‐containing plaques. In conclusion, vinexin‐β is expressed in advanced human atherosclerotic plaques, but differential expression of this protein in lesions with a thrombus versus stable plaques could not be confirmed. However, this analysis revealed expression of six isoforms of AAT in advanced plaques, one of which was uniquely expressed in thrombus‐containing plaques. Copyright © 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

[1]  Kenneth M. Yamada,et al.  Vinexin: A Novel Vinculin-binding Protein with Multiple SH3 Domains Enhances Actin Cytoskeletal Organization , 1999, The Journal of cell biology.

[2]  W. Hollander,et al.  Soluble proteins in the human atherosclerotic plaque. With spectral reference to immunoglobulins, C3-complement component, alpha 1-antitrypsin and alpha 2-macroglobulin. , 1979, Atherosclerosis.

[3]  J. Šťastný,et al.  Quantitative alteration of some aortic intima proteins in fatty streaks and fibro-fatty lesions. , 1992, Experimental and molecular pathology.

[4]  E. Petricoin,et al.  Cancer proteomics: from biomarker discovery to signal pathway profiling. , 2001, Cancer journal.

[5]  Maria Chiara Pietrogrande,et al.  Spot overlapping in two‐dimensional polyacrylamide gel electrophoresis maps: Relevance to proteomics , 2003, Electrophoresis.

[6]  Petricoin Ef rd,et al.  Cancer proteomics: from biomarker discovery to signal pathway profiling. , 2001, Cancer journal.

[7]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[8]  E. Topol,et al.  Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. , 2003, Physiological genomics.

[9]  D. Stanworth,et al.  Microheterogeneity of alpha 1-antitrypsin in relation to the concentration of its complex with immunoglobulin A in the sera of patients with rheumatoid arthritis. , 1996, Clinical and Experimental Rheumatology.

[10]  S. Janciauskiene.  Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles. , 2001, Biochimica et biophysica acta.

[11]  S. Free,et al.  Protein modification and its biological role. , 1985, The International journal of biochemistry.

[12]  W. Dichtl,et al.  The carboxyl-terminal fragment of alpha1-antitrypsin is present in atherosclerotic plaques and regulates inflammatory transcription factors in primary human monocytes. , 2000, Molecular cell biology research communications : MCBRC.

[13]  S. Gygi,et al.  Correlation between Protein and mRNA Abundance in Yeast , 1999, Molecular and Cellular Biology.

[14]  R. Virmani,et al.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[15]  G. Ciliberto,et al.  Constitutive and modulated expression of the human alpha 1 antitrypsin gene. Different transcriptional initiation sites used in three different cell types. , 1992, The Journal of clinical investigation.

[16]  W. Hollander,et al.  Soluble proteins in the human atheroschlerotic plaque , 1979 .

[17]  J. V. Van Beeumen,et al.  Automated nanoflow liquid chromatography-tandem mass spectrometry for a differential display proteomic study on Xenopus laevis neuroendocrine cells. , 2002, Journal of chromatography. A.

[18]  M. Daemen,et al.  Identification of Genes Potentially Involved in Rupture of Human Atherosclerotic Plaques , 2001, Circulation research.

[19]  P. Törönen,et al.  Changes in gene expression in atherosclerotic plaques analyzed using DNA array. , 2002, Atherosclerosis.